SOTK Sono TEK (SOTK) Q2 FY27 earnings call
Sono-Tek delivered solid first-half results driven by robust medical market growth and a strategic shift towards higher-value production systems. The company secured record orders for alternative energy and medical diagnostics, significantly boosting its backlog and providing strong visibility into fiscal year 2028. Management is focused on expanding its Forward Deployed Engineering team and manufacturing capacity to capitalize on these opportunities, while reiterating flat to modest revenue growth for the current fiscal year.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
SOTK operating KPIs by quarter
| KPI | Feb 2026 Q4 FY26 | This call Aug 2026 Q2 FY27 | Change vs prior quarter |
|---|---|---|---|
| Backlog | ~$9.12MWe ended fiscal year 2026 with a backlog of approximately $9.12 million, and that's remaining pretty close to historically high levels, and that is supporting our visibility into fiscal 2027.Source: earnings call transcript | ~$9.5MOn August 31, our backlog was approximately 9.5 million, and that's up 23% from the end of the fiscal quarter.Source: earnings call transcript | — |
Operating figures the company stated on at least two of the calls shown, checked against each call's transcript. Click a figure to read the sentence. A dash means it was not stated that quarter.
Inve summary of the company's earnings call; see how call summaries are prepared. Not investment advice.